# iRhythm Holdings to Participate in Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/IRTC/irhythm-holdings-to-participate-in-upcoming-investor-conferences-46a8c364
Ticker: IRTC
Company: iRhythm
Source: iRhythm
Published: 2026-05-19 20:05 EST
## Summary

iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted...

## Article Body
iRhythm Holdings, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that the company will be participating in the following investor conferences.

William Blair 46th Annual Growth Stock Conference on June 2, 2026, at 8:00 a.m. CT (6:00 a.m. PT) Truist Securities MedTech Conference on June 16, 2026, at 2:20 p.m. ET (11:20 a.m. PT)

Interested parties may access a live and archived webcast of the presentation on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com .

About iRhythm Holdings, Inc. iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact investors@irhythmtech.com

Media Contact Kassandra Perry mediarelations@irhythmtech.com
## Recent Company News
- 2026-07-16 20:05 EST — [iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026](https://biopharmsignal.com/news/IRTC/irhythm-holdings-to-report-second-quarter-2026-financial-results-on-august-6-202-c95df473) — Source: iRhythm
- 2026-05-19 20:05 EST — [iRhythm Holdings to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/IRTC/irhythm-holdings-to-participate-in-upcoming-investor-conferences-46a8c364) — Source: iRhythm
- 2026-04-30 20:05 EST — [iRhythm Holdings Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/IRTC/irhythm-holdings-announces-first-quarter-2026-financial-results-d2123e7c) — Source: iRhythm
- 2026-04-28 20:05 EST — [iRhythm Holdings to Present at the Bank of America Securities 2026 Health Care Conference](https://biopharmsignal.com/news/IRTC/irhythm-holdings-to-present-at-the-bank-of-america-securities-2026-health-care-c-301062b2) — Source: iRhythm
- 2026-04-27 12:05 EST — [New Data Presented at HRS 2026 Show Short-Term Holter Monitoring Misses a Large Proportion of AF Recurrence Post-Ablation and Clinically Significant Arrhythmias in Pregnancy](https://biopharmsignal.com/news/IRTC/new-data-presented-at-hrs-2026-show-short-term-holter-monitoring-misses-a-large--33898ed4) — Source: iRhythm
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)